Requests that the FDA initiate proceedings to reschedule or otherwise revise the regulatory scheduling of the following substances currently listed in Schedule I or under comparable prohibitive status, moving them to a lower schedule such as Schedule II or III when supported by scientific evidence of medical or therapeutic use under proper supervision | Federal Regulations · Congress.wiki